Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Table of Contents

June 15, 2024; Volume 21,Issue 6

Editorial

  • Open Access
    Roles of cancer-associated fibroblast functional heterogeneity in shaping the lymphatic metastatic landscape: new insights and therapeutic strategies
    Hanhao Zheng, Daiyin Liu, Zhicong Liu, Mingjie An, Yuming Luo, Changhao Chen and Tianxin Lin
    Cancer Biology & Medicine June 2024, 21 (6) 445-450; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0138

Reviews

  • Open Access
    Immune checkpoint inhibitors: breakthroughs in cancer treatment
    Xueqing Kong, Jinyi Zhang, Shuwei Chen, Xianyang Wang, Qing Xi, Han Shen and Rongxin Zhang
    Cancer Biology & Medicine June 2024, 21 (6) 451-472; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0055
  • Open Access
    Progress in clinical diagnosis and treatment of colorectal cancer with rare genetic variants
    Shuyi Chen, Jing Gu, Kaichun Wu, Xiaodi Zhao and Yuanyuan Lu
    Cancer Biology & Medicine June 2024, 21 (6) 473-483; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0026
  • Open Access
    Advances in MET tyrosine kinase inhibitors in gastric cancer
    Yifan Zhang, Lin Shen and Zhi Peng
    Cancer Biology & Medicine June 2024, 21 (6) 484-498; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0044
  • Open Access
    Revolutionizing tumor immunotherapy: unleashing the power of progenitor exhausted T cells
    Zhang Fang, Xinyi Ding, Hao Huang, Hongwei Jiang, Jingting Jiang and Xiao Zheng
    Cancer Biology & Medicine June 2024, 21 (6) 499-512; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0105

Original Article

  • Open Access
    Decreased LDHB expression in breast tumor cells causes NK cell activation and promotes tumor progression
    Zhihong Luo, Xiaohua Huang, Xinyi Xu, Kefeng Wei, Yi Zheng, Ke Gong and Wenhua Li
    Cancer Biology & Medicine June 2024, 21 (6) 513-540; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0382
Back to top
PreviousNext

In this issue

Cancer Biology & Medicine: 21 (6)
Cancer Biology & Medicine
Vol. 21, Issue 6
15 Jun 2024
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

Jump to

  • Editorial
  • Reviews
  • Original Article

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire